GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » Cyclically Adjusted PS Ratio

3B BlackBio Dx (BOM:532067) Cyclically Adjusted PS Ratio : 8.97 (As of Jun. 06, 2024)


View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx Cyclically Adjusted PS Ratio?

As of today (2024-06-06), 3B BlackBio Dx's current share price is ₹852.05. 3B BlackBio Dx's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹95.04. 3B BlackBio Dx's Cyclically Adjusted PS Ratio for today is 8.97.

The historical rank and industry rank for 3B BlackBio Dx's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:532067' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.71   Med: 5.49   Max: 10.27
Current: 8.96

During the past years, 3B BlackBio Dx's highest Cyclically Adjusted PS Ratio was 10.27. The lowest was 3.71. And the median was 5.49.

BOM:532067's Cyclically Adjusted PS Ratio is ranked worse than
63.49% of 504 companies
in the Biotechnology industry
Industry Median: 5.525 vs BOM:532067: 8.96

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

3B BlackBio Dx's adjusted revenue per share data for the three months ended in Mar. 2024 was ₹26.609. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹95.04 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


3B BlackBio Dx Cyclically Adjusted PS Ratio Historical Data

The historical data trend for 3B BlackBio Dx's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx Cyclically Adjusted PS Ratio Chart

3B BlackBio Dx Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 3.93 4.23 4.72 8.10

3B BlackBio Dx Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.72 4.63 8.57 8.47 8.10

Competitive Comparison of 3B BlackBio Dx's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, 3B BlackBio Dx's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3B BlackBio Dx's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's Cyclically Adjusted PS Ratio falls into.



3B BlackBio Dx Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

3B BlackBio Dx's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=852.05/95.04
=8.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3B BlackBio Dx's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, 3B BlackBio Dx's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=26.609/153.0345*153.0345
=26.609

Current CPI (Mar. 2024) = 153.0345.

3B BlackBio Dx Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.255 94.103 6.920
201409 10.165 96.780 16.073
201412 4.830 96.780 7.637
201503 9.897 97.163 15.588
201506 4.334 99.841 6.643
201509 8.606 101.753 12.943
201512 7.796 102.901 11.594
201603 7.019 102.518 10.478
201606 3.933 105.961 5.680
201609 9.534 105.961 13.769
201612 6.754 105.196 9.825
201703 5.054 105.196 7.352
201706 6.549 107.109 9.357
201709 12.278 109.021 17.235
201712 9.198 109.404 12.866
201803 8.996 109.786 12.540
201806 6.739 111.317 9.265
201809 10.940 115.142 14.540
201812 7.276 115.142 9.670
201903 8.477 118.202 10.975
201906 7.497 120.880 9.491
201909 12.834 123.175 15.945
201912 9.149 126.235 11.091
202003 8.978 124.705 11.018
202006 70.445 127.000 84.886
202009 170.554 130.118 200.592
202012 56.865 130.889 66.486
202103 25.149 131.771 29.207
202106 43.511 134.084 49.660
202109 23.191 135.847 26.125
202112 19.125 138.161 21.184
202203 24.506 138.822 27.015
202206 18.139 142.347 19.501
202209 19.960 144.661 21.115
202212 19.698 145.763 20.681
202303 23.701 146.865 24.697
202306 21.768 150.280 22.167
202309 21.631 151.492 21.851
202312 20.131 152.924 20.146
202403 26.609 153.035 26.609

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


3B BlackBio Dx  (BOM:532067) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


3B BlackBio Dx Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


3B BlackBio Dx (BOM:532067) Business Description

Traded in Other Exchanges
N/A
Address
7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines